Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 14Not yet recruiting 8Completed 2Terminated 1

Sponsor Class

OTHER 102INDUSTRY 21OTHER_GOV 2NIH 2UNKNOWN 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 107Neoplasms 80Colorectal Neoplasms 54Uterine Cervical Neoplasms 29Stomach Neoplasms 29Lung Neoplasms 27Rectal Neoplasms 25Prostatic Neoplasms 25Colonic Neoplasms 24Polycystic Ovary Syndrome 22Pancreatic Neoplasms 22Head and Neck Neoplasms 17Endometrial Neoplasms 17Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 16Pain 15Neoplasm Metastasis 15Motor Activity 15Esophageal Neoplasms 15Ovarian Neoplasms 13Urinary Bladder Neoplasms 11Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Pain, Postoperative 10Melanoma 10Thyroid Neoplasms 9Pilonidal Sinus 9Multiple Myeloma 9Gastrointestinal Neoplasms 9Sarcopenia 8

Interventions

Gemcitabine 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × Nasopharyngeal Carcinoma × Clear all
NCT04387266 2020-10-09

To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC

Fujian Cancer Hospital

Completed
471 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Ministry of Health, Malaysia

Phase 2 Completed
18 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡